Ieva Jasiukenaite will take on an important role in defining communication strategy for ZERION and ensure high quality content and news updates for our followers on the website and social media platforms. Ieva joins ZERION with 6+ years of experience working with strategic communication and digital marketing as well as graphical design.
Camila Belavi will support the formulation team in the pre-clinical experimental activities of Dispersome® formulations for ZERION’s drug development programs. Camila joins ZERION with 3+ years of industry experience working with pharmaceutical formulation development including controlled release drug projects with poorly soluble drug compounds and biopolymers.
We are excited to have Ieva and Camila join our team and take part in our journey to commercialize our Dispersome® medicinal products.
September 25, 2023 (COPENHAGEN, Denmark). Zerion Pharma A/S (“ZERION”) today announces that the Company has elected Mr. Carl-Åke Carlsson as its new Chairman of the Board of Directors.
September 1, 2023 (COPENHAGEN, Denmark). Zerion Pharma A/S (“ZERION”) today announces that the Company has strengthened its management team with the appointment of Dr. Mads Aaboe Jensen as Vice President Business
June 8, 2023 (COPENHAGEN, Denmark). Zerion Pharma A/S (“ZERION”) today announces the publication of joint experimental work on its Dispersome® technology in the International Journal of Pharmaceutics and ...